<\/p>\n
Niftas je nitrofurantoinov\u00e1 tableta pro nekomplikovan\u00e9 infekce doln\u00edch mo\u010dov\u00fdch cest u \u017een. NEPOU\u017d\u00cdVAT pro pyelonefritidu. Vyvarujte se p\u0159i CrCl < 45. Vyrobeno podle standard\u016f WHO-GMP.<\/p>\n<\/div>\n
\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n Niftas je l\u00e9\u010divo obsahuj\u00edc\u00ed \u00fa\u010dinnou l\u00e1tku Nitrofurantoin. Pat\u0159\u00ed do t\u0159\u00eddy antibiotik zn\u00e1m\u00fdch jako nitrofurany a prim\u00e1rn\u011b se pou\u017e\u00edv\u00e1 k l\u00e9\u010db\u011b infekc\u00ed mo\u010dov\u00fdch cest (UTI) zp\u016fsoben\u00fdch ur\u010dit\u00fdmi bakteriemi. Dostupn\u00e9 v peror\u00e1ln\u00edch kapsl\u00edch i suspenzi, Niftas p\u016fsob\u00ed inhibic\u00ed r\u016fstu a reprodukce bakteri\u00ed zodpov\u011bdn\u00fdch za UTI. \u010casto je p\u0159edepisov\u00e1n pro akutn\u00ed i chronick\u00e9 UTI, poskytuje \u00fa\u010dinnou \u00falevu od p\u0159\u00edznak\u016f, jako je bolestiv\u00e9 mo\u010den\u00ed, \u010dast\u00e9 mo\u010den\u00ed a bolesti v podb\u0159i\u0161ku.<\/p>\n Niftas je indikov\u00e1n k l\u00e9\u010db\u011b infekc\u00ed mo\u010dov\u00fdch cest zp\u016fsoben\u00fdch citliv\u00fdmi kmeny bakteri\u00ed, v\u010detn\u011b Escherichia coli, Enterococcus species a Staphylococcus aureus. Je \u00fa\u010dinn\u00fd proti infekc\u00edm doln\u00edch i horn\u00edch mo\u010dov\u00fdch cest, v\u010detn\u011b cystitidy a pyelonefritidy. Niftas p\u016fsob\u00ed interferenc\u00ed se synt\u00e9zou bakteri\u00e1ln\u00ed bun\u011b\u010dn\u00e9 st\u011bny, co\u017e vede k odum\u0159en\u00ed bakteri\u00e1ln\u00ed bu\u0148ky a vy\u0159e\u0161en\u00ed infekce. \u010casto je p\u0159edepisov\u00e1n jako l\u00e9\u010dba prvn\u00ed volby pro nekomplikovan\u00e9 UTI d\u00edky sv\u00e9 \u00fa\u010dinnosti a n\u00edzk\u00e9mu riziku rezistence.<\/p>\n Niftas se obvykle u\u017e\u00edv\u00e1 peror\u00e1ln\u011b s plnou sklenic\u00ed vody, nejl\u00e9pe s j\u00eddlem, aby se minimalizovaly gastrointestin\u00e1ln\u00ed vedlej\u0161\u00ed \u00fa\u010dinky. D\u00e1vkov\u00e1n\u00ed a d\u00e9lka l\u00e9\u010dby z\u00e1vis\u00ed na z\u00e1va\u017enosti infekce a v\u011bku a ren\u00e1ln\u00ed funkci pacienta. Je d\u016fle\u017eit\u00e9 u\u017e\u00edvat Niftas p\u0159esn\u011b podle pokyn\u016f zdravotnick\u00e9ho pracovn\u00edka a dokon\u010dit cel\u00fd pr\u016fb\u011bh l\u00e9\u010dby, i kdy\u017e se p\u0159\u00edznaky zlep\u0161\u00ed d\u0159\u00edve, ne\u017e je l\u00e9\u010dba ukon\u010dena. Nedodr\u017een\u00ed m\u016f\u017ee v\u00e9st k opakov\u00e1n\u00ed infekce nebo rozvoji antibiotick\u00e9 rezistence.<\/p>\n Nitrofurantoin, \u00fa\u010dinn\u00e1 l\u00e1tka v p\u0159\u00edpravku Niftas, p\u016fsob\u00ed inhibic\u00ed synt\u00e9zy bakteri\u00e1ln\u00edch bun\u011b\u010dn\u00fdch st\u011bn, co\u017e nakonec vede k odum\u0159en\u00ed bakteri\u00e1ln\u00edch bun\u011bk. Sv\u00e9ho baktericidn\u00edho \u00fa\u010dinku dosahuje interferenc\u00ed s v\u00edce enzymatick\u00fdmi procesy pod\u00edlej\u00edc\u00edmi se na tvorb\u011b slo\u017eek bakteri\u00e1ln\u00ed bun\u011b\u010dn\u00e9 st\u011bny. Nitrofurantoin nav\u00edc m\u016f\u017ee po\u0161kozovat bakteri\u00e1ln\u00ed DNA, co\u017e d\u00e1le p\u0159isp\u00edv\u00e1 k jeho antimikrobi\u00e1ln\u00ed aktivit\u011b. C\u00edlen\u00edm na kl\u00ed\u010dov\u00e9 slo\u017eky bakteri\u00e1ln\u00ed struktury a funkce p\u0159\u00edpravek Niftas \u00fa\u010dinn\u011b eliminuje bakterie zodpov\u011bdn\u00e9 za infekce mo\u010dov\u00fdch cest.<\/p>\n Doporu\u010den\u00e9 d\u00e1vkov\u00e1n\u00ed p\u0159\u00edpravku Niftas u nekomplikovan\u00fdch infekc\u00ed mo\u010dov\u00fdch cest u dosp\u011bl\u00fdch je obvykle 50 a\u017e 100 mg peror\u00e1ln\u011b \u010dty\u0159ikr\u00e1t denn\u011b po dobu 7 dn\u016f. Pro prevenci recidivuj\u00edc\u00edch infekc\u00ed mo\u010dov\u00fdch cest se \u010dasto p\u0159edepisuje ni\u017e\u0161\u00ed d\u00e1vka 50 a\u017e 100 mg peror\u00e1ln\u011b p\u0159ed span\u00edm. U pacient\u016f s ren\u00e1ln\u00ed insuficienc\u00ed mohou b\u00fdt nutn\u00e9 \u00fapravy d\u00e1vkov\u00e1n\u00ed, proto\u017ee nitrofurantoin je prim\u00e1rn\u011b vylu\u010dov\u00e1n ledvinami. Pro zaji\u0161t\u011bn\u00ed optim\u00e1ln\u00edch v\u00fdsledk\u016f l\u00e9\u010dby je d\u016fle\u017eit\u00e9 dodr\u017eovat d\u00e1vkovac\u00ed pokyny poskytnut\u00e9 zdravotnick\u00fdm pracovn\u00edkem.<\/p>\n P\u0159\u00edpravek Niftas nab\u00edz\u00ed n\u011bkolik v\u00fdhod pro pacienty s infekcemi mo\u010dov\u00fdch cest. Poskytuje \u00fa\u010dinnou \u00falevu od p\u0159\u00edznak\u016f, jako je dysurie, urgentn\u00ed nucen\u00ed na mo\u010den\u00ed a \u010dast\u00e9 mo\u010den\u00ed spojen\u00e9 s UTI, \u010d\u00edm\u017e zlep\u0161uje kvalitu \u017eivota pacienta. Niftas je obecn\u011b dob\u0159e sn\u00e1\u0161en a m\u00e1 ni\u017e\u0161\u00ed riziko syst\u00e9mov\u00fdch ne\u017e\u00e1douc\u00edch \u00fa\u010dink\u016f ve srovn\u00e1n\u00ed s jin\u00fdmi antibiotiky. Jeho \u0161irok\u00e9 spektrum \u00fa\u010dinku a pohodln\u00fd d\u00e1vkovac\u00ed re\u017eim z n\u011bj \u010din\u00ed preferovanou volbu pro l\u00e9\u010dbu a prevenci infekc\u00ed mo\u010dov\u00fdch cest.<\/p>\n Mezi b\u011b\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky p\u0159\u00edpravku Niftas m\u016f\u017ee pat\u0159it nevolnost, zvracen\u00ed, pr\u016fjem, bolesti b\u0159icha a bolest hlavy. Tyto ne\u017e\u00e1douc\u00ed \u00fa\u010dinky jsou obvykle m\u00edrn\u00e9 a p\u0159echodn\u00e9, samy odezn\u00ed bez nutnosti l\u00e9ka\u0159sk\u00e9ho z\u00e1sahu. Pokud v\u0161ak jak\u00e9koli ne\u017e\u00e1douc\u00ed \u00fa\u010dinky p\u0159etrv\u00e1vaj\u00ed nebo se zhor\u0161uj\u00ed, je d\u016fle\u017eit\u00e9 vyhledat l\u00e9ka\u0159e k dal\u0161\u00edmu vy\u0161et\u0159en\u00ed a \u0159e\u0161en\u00ed.<\/p>\n P\u0159\u00edpravek Niftas by m\u011bl b\u00fdt pou\u017e\u00edv\u00e1n s opatrnost\u00ed u pacient\u016f se zn\u00e1mou p\u0159ecitliv\u011blost\u00ed na nitrofurantoin nebo jakoukoli jinou slo\u017eku p\u0159\u00edpravku. Je kontraindikov\u00e1n u pacient\u016f s ren\u00e1ln\u00ed insuficienc\u00ed, jatern\u00ed insuficienc\u00ed nebo anamn\u00e9zou cholestatick\u00e9 \u017eloutenky spojen\u00e9 s u\u017e\u00edv\u00e1n\u00edm nitrofurantoinu. Dlouhodob\u00e9 u\u017e\u00edv\u00e1n\u00ed p\u0159\u00edpravku Niftas m\u016f\u017ee zv\u00fd\u0161it riziko antibiotick\u00e9 rezistence a rozvoje rezistentn\u00edch bakteri\u00ed. P\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby je d\u016fle\u017eit\u00e9 prodiskutovat rizika a p\u0159\u00ednosy p\u0159\u00edpravku Niftas s l\u00e9ka\u0159em.<\/p>\n Skladujte tobolky a suspenzi Niftas p\u0159i pokojov\u00e9 teplot\u011b mimo dosah vlhkosti a tepla. Uchov\u00e1vejte l\u00e9k mimo dosah d\u011bt\u00ed a dom\u00e1c\u00edch zv\u00ed\u0159at. Nepou\u017e\u00edvejte p\u0159\u00edpravek Niftas po uplynut\u00ed data exspirace uveden\u00e9ho na obalu. Pokud po ukon\u010den\u00ed l\u00e9\u010dby z\u016fstanou nepou\u017eit\u00e9 l\u00e9ky, zlikvidujte je \u0159\u00e1dn\u011b v souladu s m\u00edstn\u00edmi p\u0159edpisy.<\/p>\n Na\u0161\u00edm jedin\u00fdm z\u00e1m\u011brem je zajistit, aby spot\u0159ebitel\u00e9 z\u00edskali informace, kter\u00e9 jsou odborn\u011b ov\u011b\u0159en\u00e9, p\u0159esn\u00e9 a d\u016fv\u011bryhodn\u00e9. Informace zde obsa\u017een\u00e9 by v\u0161ak NEM\u011aLY b\u00fdt pou\u017e\u00edv\u00e1ny jako n\u00e1hrada za radu kvalifikovan\u00e9ho l\u00e9ka\u0159e. Informace poskytovan\u00e9 zde jsou pouze pro informa\u010dn\u00ed \u00fa\u010dely. Nemus\u00ed zahrnovat v\u0161echny mo\u017en\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky, l\u00e9kov\u00e9 interakce, varov\u00e1n\u00ed nebo upozorn\u011bn\u00ed. Pros\u00edm, pora\u010fte se se sv\u00fdm l\u00e9ka\u0159em a proberte v\u0161echny sv\u00e9 dotazy t\u00fdkaj\u00edc\u00ed se jak\u00e9hokoli onemocn\u011bn\u00ed nebo l\u00e9ku. Na\u0161\u00edm c\u00edlem je podporovat, nikoli nahrazovat, vztah mezi l\u00e9ka\u0159em a pacientem.<\/p>\n Niftas je nitrofurantoin \u2014 l\u00e9k prvn\u00ed volby u nekomplikovan\u00fdch infekc\u00ed doln\u00edch mo\u010dov\u00fdch cest (cystitidy) u dosp\u011bl\u00fdch a star\u0161\u00edch d\u011bt\u00ed. Koncentruje se v mo\u010di, ale dosahuje zanedbateln\u00fdch hladin v tk\u00e1n\u00edch, proto se NEPOU\u017d\u00cdV\u00c1 u pyelonefritidy, prostatitidy ani jak\u00fdchkoli mimo-mo\u010dov\u00fdch infekc\u00ed.<\/p>\n Nitrofurantoin nedosahuje dostate\u010dn\u00fdch koncentrac\u00ed v ren\u00e1ln\u00edm parenchymu. Pyelonefritida vy\u017eaduje l\u00e9\u010divo, kter\u00e9 dos\u00e1hne syst\u00e9mov\u00fdch a ledvinn\u00fdch hladin (obvykle fluorochinolon, cefalosporin t\u0159et\u00ed generace nebo aminoglykosid).<\/p>\n 5 dn\u00ed u akutn\u00ed nekomplikovan\u00e9 cystitidy (modern\u00ed doporu\u010den\u00ed, stejn\u00e1 \u00fa\u010dinnost jako u 7denn\u00edch re\u017eim\u016f s lep\u0161\u00ed sn\u00e1\u0161enlivost\u00ed). Dlouhodob\u00e1 profylaxe v n\u00edzk\u00fdch d\u00e1vk\u00e1ch (50\u2013100 mg na noc) m\u016f\u017ee b\u00fdt pou\u017eita u recidivuj\u00edc\u00edch UTI pod odborn\u00fdm dohledem.<\/p>\n Ne \u2014 nitrofurantoin je kontraindikov\u00e1n p\u0159i clearance kreatininu pod 45 ml\/min (n\u011bkter\u00e1 doporu\u010den\u00ed p\u0159ipou\u0161t\u011bj\u00ed a\u017e 30 ml\/min u kr\u00e1tk\u00fdch l\u00e9\u010debn\u00fdch re\u017eim\u016f). Sn\u00ed\u017een\u00e1 ren\u00e1ln\u00ed funkce zhor\u0161uje koncentraci v mo\u010di A zvy\u0161uje riziko syst\u00e9mov\u00e9 toxicity. U star\u0161\u00edch pacient\u016f v\u017edy p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby zkontrolujte ren\u00e1ln\u00ed funkce.<\/p>\n Akutn\u00ed nebo chronick\u00e1 plicn\u00ed fibr\u00f3za, chronick\u00e1 aktivn\u00ed hepatitida a perifern\u00ed neuropatie \u2014 v\u0161echny vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9. Riziko prudce stoup\u00e1 p\u0159i l\u00e9\u010db\u011b del\u0161\u00ed ne\u017e 6 m\u011bs\u00edc\u016f. P\u0159i dlouhodob\u00e9 profylaxi je nutn\u00e1 ka\u017edoro\u010dn\u00ed kontrola.<\/p>\n Hn\u011bd\u00e1 nebo rezav\u011b zbarven\u00e1 mo\u010d je norm\u00e1ln\u00ed ne\u0161kodn\u00fd \u00fa\u010dinek nitrofurantoinu a jeho metabolit\u016f \u2014 nejde o zn\u00e1mku krv\u00e1cen\u00ed nebo po\u0161kozen\u00ed ledvin. Vrac\u00ed se do norm\u00e1lu b\u011bhem n\u011bkolika dn\u00ed po ukon\u010den\u00ed l\u00e9\u010dby.<\/p>\n <\/p>\n \u2705 L\u00e9\u010d\u00ed infekce mo\u010dov\u00fdch cest Niftas obsahuje Nitrofurantoin.<\/p>","protected":false},"featured_media":59474,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3484,3141,3342],"product_tag":[4702,4516],"class_list":{"0":"post-59473","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-antibiotics","7":"product_cat-category-overview","8":"product_cat-general-health","9":"product_tag-niftas","10":"product_tag-nitrofurantoin","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/59473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=59473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/59474"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=59473"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=59473"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=59473"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=59473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n
P\u0159ehled produktu<\/strong><\/h2>\n
Pou\u017eit\u00ed<\/strong><\/h2>\n
Jak pou\u017e\u00edvat<\/strong><\/h2>\n
Jak p\u016fsob\u00ed<\/strong><\/h2>\n
D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/strong><\/h2>\n
V\u00fdhody<\/strong><\/h2>\n
B\u011b\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky<\/strong><\/h2>\n
Varov\u00e1n\u00ed<\/strong><\/h2>\n
Informace o skladov\u00e1n\u00ed<\/strong><\/h2>\n
Odm\u00edtnut\u00ed odpov\u011bdnosti:<\/strong><\/h2>\n
\u010casto kladen\u00e9 dotazy<\/h2>\n
K \u010demu se p\u0159\u00edpravek Niftas pou\u017e\u00edv\u00e1?<\/h3>\n
Pro\u010d se Niftas nepou\u017e\u00edv\u00e1 u infekc\u00ed ledvin?<\/h3>\n
Jak\u00e1 je obvykl\u00e1 d\u00e9lka l\u00e9\u010dby?<\/h3>\n
Je Niftas bezpe\u010dn\u00fd p\u0159i sn\u00ed\u017een\u00e9 funkci ledvin?<\/h3>\n
Jak\u00e9 z\u00e1va\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky m\u016f\u017ee Niftas zp\u016fsobit p\u0159i dlouhodob\u00e9m u\u017e\u00edv\u00e1n\u00ed?<\/h3>\n
Pro\u010d Niftas barv\u00ed mo\u010d do hn\u011bda?<\/h3>\n
Dal\u0161\u00ed protiz\u00e1n\u011btliv\u00e9 l\u00e9ky<\/h2>\n
\n
\n\u2705 Bojuje proti bakteri\u00e1ln\u00edm infekc\u00edm
\n\u2705 Zm\u00edr\u0148uje p\u0159\u00edznaky UTI
\n\u2705 Zabr\u00e1\u0148uje opakov\u00e1n\u00ed infekce mo\u010dov\u00fdch cest
\n\u2705 \u00da\u010dinn\u00e9 antimikrobi\u00e1ln\u00ed \u010dinidlo<\/p>\n